Posts tagged "Alzheimer’s disease"

Biotech startup Inflazome has raised $63 million to commercialise its drug slowing the progress of inflammatory diseases like Alzheimer’s and Parkinson’s.

Medical AI startup Maxwell Plus has secured a $1.1 million grant to commercialise tech for diagnosing Alzheimer’s disease, in collaboration with CSIRO.